Amarantus Bioscience Holdings Inc (AMBS)

[Snibe]

Amarantus Bioscience Holdings, Inc. (OTCQB:AMBS), a biotechnology company focused on the discovery and development of novel diagnostics and therapeutics related to endoplasmic reticulum stress, cell cycle dysregulation, neurodegeneration and apoptosis, today announced that Gerald Commissiong, President and CEO will be presenting at the 2014 BIO International Convention on Thursday, June 26 at 11:45 AM PDT. The presentation will take place in the Mission Beach Room. Hosted by the Biotechnology Industry Organization (BIO), the conference will take place on June 23-26, 2014 at the San Diego Convention Center in San Diego, California.
Business development representatives from the Company will be participating in the Partnering Forum at the Convention. The Company has 45 one-on-one meetings scheduled, and has availability for 5 additional meetings. For meeting requests, please email [e-mail].